Lv53
980 积分 2024-08-26 加入
Recent advances in nuclear receptor-binding SET domain 2 (NSD2) inhibitors: An update and perspectives
2天前
已完结
NSD2 promotes cell durotaxis and drives the transition from polycystic kidney disease to tubulocystic renal cell carcinoma through integrin/FAK/AKT signaling
6天前
已完结
NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers
9天前
已完结
Reduced Accumbal Dopamine Efflux Via Orexin OX2 Receptors in Chronic Pain Models
22天前
已完结
Reduced Accumbal Dopamine Efflux Via Orexin OX2 Receptors in Chronic Pain Models
22天前
已完结
Design and Synthesis of Orexin 1 Receptor-Selective Agonists
22天前
已完结
The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target
22天前
已完结
Lemborexant ameliorates tau-mediated sleep loss and neurodegeneration in males in a mouse model of tauopathy
23天前
已完结
Discovery of a New Class of Orexin 2 Receptor Agonists as a Potential Treatment for Narcolepsy
27天前
已完结
The immunopathogenesis of narcolepsy type 1
27天前
已完结
皖公网安备34019202002308
